Central Peninsula General Hospital Serenity House Residential Treatment
-
Services:
- State Substance use treatment agency
- The Joint Commission
- State department of health
- Hospital licensing authority
- State mental health department
- Transitional housing, halfway house, or sober home
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Detoxification
- Substance use treatment
- Housing services
- Assistance with obtaining social services
- Mentoring/peer support
- Self-help groups
- Employment counseling or training
- Screening for substance use
- Screening for mental disorders
- Screening for tobacco use
- Comprehensive mental health assessment
- Outreach to persons in the community
- Comprehensive substance use assessment
- Interim services for clients
- Professional interventionist/educational consultant
- Complete medical history/physical exam
- Treatment for other addiction disorder
- Outcome follow-up after discharge
- Aftercare/continuing care
- Naloxone and overdose education
- Discharge Planning
- General Hospital (including VA hospital)
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Sign language services for the deaf and hard of hearing
- Individual counseling
- Group counseling
- Health education services other than HIV/AIDS or hepatitis
- Substance use disorder education
- Smoking/vaping/tobacco cessation counseling
- Family counseling
- Vocational training or educational support (for example, high school coursework, GED preparation, etc.)
- Hepatitis education, counseling, or support
- HIV or AIDS education, counseling, or support
- Marital/couples counseling
- Substance use disorder counseling
- Anger management
- Matrix Model
- Motivational interviewing
- Brief intervention
- Contingency management/motivational incentives
- Relapse prevention
- Trauma-related counseling
- 12-step facilitation
- Cognitive behavioral therapy
- Telemedicine/telehealth therapy
- Female
- Male
- Benzodiazepines Detoxification
- Cocaine Detoxification
- Opioids detoxification
- Alcohol Detoxification
- Methamphetamines detoxification
- Medication routinely used during detoxification
- State-financed health insurance plan other than Medicaid
- Private health insurance
- Federal, or any government funding for substance use treatment programs
- Cash or self-payment
- Medicare
- Federal military insurance (e.g., TRICARE)
- Medicaid
- Medication for mental disorders
- Clonidine
- Non-nicotine smoking/tobacco cessation
- Medications for Hepatitis C treatment
- Disulfiram
- Medications for HIV treatment
- Buprenorphine with naloxone
- Lofexidine
- Acamprosate (CampralĀ®)
- Naltrexone (oral)
- Naltrexone (extended-release, injectable)
- Buprenorphine (extended-release, injectable)
- Buprenorphine without naloxone
- Medications for pre-exposure to prophylaxis
- Nicotine replacement
- Private non-profit organization
- Vaping not permitted
- Outpatient
- Intensive outpatient treatment
- Residential detoxification
- Outpatient detoxification
- Regular outpatient treatment
- Long-term residential
- Residential/24-hour residential
- Short-term residential
- Outpatient methadone/buprenorphine or naltrexone treatment
- Young Adults
- Adults
- Clients who have experienced trauma
- Veterans
- Clients who have experienced intimate partner violence, domestic violence
- Adult men
- Active duty military
- Members of military families
- Clients with HIV or AIDS
- Young adults
- Adult women
- Clients with co-occurring pain and substance use disorders
- Pregnant/postpartum women
- Seniors or older adults
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Clients who have experienced sexual abuse
- Clients with co-occurring mental and substance use disorders
- Criminal justice (other than DUI/DWI)/Forensic clients
- Testing for Hepatitis B (HBV)
- HIV testing
- Drug or alcohol urine screening
- Metabolic syndrome monitoring
- Drug and alcohol oral fluid testing
- STD testing
- TB screening
- Breathalyzer or blood alcohol testing
- Testing for Hepatitis C (HCV)
- Buprenorphine maintenance
- Maintenance service with medically supervised withdrawal after stabilization
- Prescribes naltrexone
- Buprenorphine detoxification
- Lofexidine or Clonidine detoxification
- Prescribes buprenorphine
- Accepts clients using MAT but prescribed elsewhere
- Relapse prevention with naltrexone
- Social skills development
- Mental health services
- Transportation assistance
- Suicide prevention services
- Case management service
- Early intervention for HIV
- Domestic violence services, including family or partner
- Smoking not permitted
- In-network prescribing entity
- No formal relationship with prescribing entity
- Other contracted prescribing entity
- Other contracted prescribing entity
- No formal relationship with prescribing entity
- In-network prescribing entity
- Hepatitis A (HAV) vaccination
- Hepatitis B (HBV) vaccination
- This facility administers/prescribes medication for alcohol use disorder
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
License/Certification/Accreditation
Type of Care
Recovery Support Services
Assessment/Pre-treatment
Other Services
Transitional Services
Hospitals
Opioid Medications used in Treatment
Language Services
Education and Counseling Services
Treatment Approaches
Gender Accepted
Detoxification (medical withdrawal) Services
Payment/Insurance/Funding Accepted
Pharmacotherapies
Facility Operation (e.g., Private, Public)
Facility Vaping Policy
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Age Groups Accepted
Special Programs/Groups Offered
Testing
Type of Opioid Treatment
Ancillary Services
Facility Smoking Policy
External Opioid Medications Source
External Source of Medications Used for Alcohol Use Disorder Treatment
Medical Services
Type of Alcohol Use Disorder Treatment